← Back to Patent Explorer
US4148897A Expired / Lapsed US ⏱️ 0.0 years remaining

1,2-Dihydronaphthalene derivatives and pharmaceutical composition

Assignee: Takeda Pharmaceutical Co Ltd
•
Filing: 1977-04-20
•
Granted: 1979-04-10
•
Expires: 1997-04-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel 1,2-dihydronaphthalene derivatives of the formula ##STR1## wherein R 1 and R 2 , independently of each other, are hydrogen, nitro, amino, halogen, or hydroxyl which may be protected, and R 3 is a piperazinyl or morpholino group which may be substituted by lower alkyl, aralkyl, carboxylic acid-derived acyl, lower alkoxycarbonyl-lower alkyl or cycloaminocarbonyl-lower alkyl, and its salts have excellent pharmacological activities such as vasodilator and cerebral blood flow increasing activities.

Inventors

  • 👤 Yoshikazu Oka
  • 👤 Katsumi Itoh
  • 👤 Akio Miyake
  • 👤 Minoru Hirata

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 03:58
CPC Classifications
C; C07; C07D; C07D295/00; C07D295/16; C07D295/18; C07D295/182; C07D295/185; A; A61; A61P; A61P43/00; A61P9/00; A61P9/08; C07D295/04; C07D295/08; C07D295/096; C07D295/10; C07D295/112; C07D295/116; C07D295/14; C07D295/145; C07D295/15; C07D295/192

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 125 words
A member of the group consisting of (a) a compound of the formula ##STR41## wherein R 1 and R 2 , independently of each other, are hydrogen, nitro, amino, halogen, hydroxyl, lower alkoxy containing up to 5 carbon atoms or aralkyloxy containing a total of 7 to 12 carbon atoms, or R 1 and R 2 may, taken together, form lower alkylenedioxy containing up to 3 carbon atoms, and R 3 is 1-piperazinyl substituted at the N 4 -position by aralkyl consisting of a straight-chain lower alkyl of 1 to 3 carbon atoms substituted at the ω-position by one or two phenyls, or by carboxylic acid-derived acyl containing a total of up to 10 carbon atoms, and (b) a physiologically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 125 words
A member of the group consisting of (a) a compound of the formula ##STR41## wherein R 1 and R 2 , independently of each other, are hydrogen, nitro, amino, halogen, hydroxyl, lower alkoxy containing up to 5 carbon atoms or aralkyloxy containing a total of 7 to 12 carbon atoms, or R 1 and R 2 may, taken together, form lower alkylenedioxy containing up to 3 carbon atoms, and R 3 is 1-piperazinyl substituted at the N 4 -position by aralkyl consisting of a straight-chain lower alkyl of 1 to 3 carbon atoms substituted at the ω-position by one or two phenyls, or by carboxylic acid-derived acyl containing a total of up to 10 carbon atoms, and (b) a physiologically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 10 words
A compound according to claim 1 wherein aralkyl is benzhydryl.
Claim 4
Dependent Claim 28 words
A compound according to claim 1 wherein R 1 and R 2 are lower alkoxy and R 3 is 1-piperazinyl substituted at the N 4 -position by aralkyl.
Claim 5
Dependent Claim 29 words
A compound according to claim 1 wherein R 1 is lower alkoxy, R 2 is hydrogen and R 3 is 1-piperazinyl substituted at the N 4 -position by aralkyl.
Claim 6
Dependent Claim 10 words
A compound according to claim 1, said compound being 3-(4-benzhydryl-1-piperazinylmethyl)-7,8-dimethoxy-1,2-dihydronaphthalene.
Claim 7
Dependent Claim 10 words
A compound according to claim 1, said compound being 3-(4-benzhydryl-1-piperazinylmethyl)-1,2-dihydronaphthalene.
Claim 8
Dependent Claim 10 words
A compound according to claim 1, said compound being 3-(4-benzhydryl-1-piperazinylmethyl)-6,7-dimethoxy-1,2-dihydronaphthalene.
Claim 9
Dependent Claim 10 words
A compound according to claim 1, said compound being 3-(4-benzhydryl-1-piperazinylmethyl)-7-methoxy-1,2-dihydronaphthalene.
Claim 10
Dependent Claim 10 words
A compound according to claim 1, said compound being 3-(4-benzhydryl-1-piperazinylmethyl)-7-n-butyloxy-1,2-dihydronaphthalene.
Claim 11
Dependent Claim 10 words
A compound according to claim 1, said compound being 3-(4-benzhydryl-1-piperazinylmethyl)-6,7-methylenedioxy-1,2-dihydronaphthalene.
Claim 12
Dependent Claim 10 words
A compound according to claim 1, said compound being 3-(4-benzyl-1-piperazinylmethyl)-6,7-dimethoxy-1,2-dihydronaphthalene.
Claim 13
Dependent Claim 146 words
A pharmaceutical composition which comprises, as the active ingredient, at least one member of the group consisting of (a) a compound of the formula ##STR42## wherein R 1 and R 2 , independently of each other, are hydrogen, nitro, amino, halogen, hydroxyl, lower alkoxy containing up to 5 carbon atoms or aralkyloxy containing a total of 7 to 12 carbon atoms, or R 1 and R 2 may, taken together, form lower alkylenedioxy containing up to 3 carbon atoms, and R 3 is 1-piperazinyl substituted at the N 4 -position by aralkyl consisting of a straight-chain lower alkyl of 1 to 3 carbon atoms substituted at the ω-position by one or two phenyls, or by carboxylic acid-derived acyl containing a total of up to 10 carbon atoms, and (b) a physiologically acceptable acid addition salt thereof, in admixture with pharmaceutically acceptable carrier, excipient or diluent therefor.
Claim 14
Dependent Claim 146 words
A pharmaceutical composition which comprises, as the active ingredient, at least one member of the group consisting of (a) a compound of the formula ##STR42## wherein R 1 and R 2 , independently of each other, are hydrogen, nitro, amino, halogen, hydroxyl, lower alkoxy containing up to 5 carbon atoms or aralkyloxy containing a total of 7 to 12 carbon atoms, or R 1 and R 2 may, taken together, form lower alkylenedioxy containing up to 3 carbon atoms, and R 3 is 1-piperazinyl substituted at the N 4 -position by aralkyl consisting of a straight-chain lower alkyl of 1 to 3 carbon atoms substituted at the ω-position by one or two phenyls, or by carboxylic acid-derived acyl containing a total of up to 10 carbon atoms, and (b) a physiologically acceptable acid addition salt thereof, in admixture with pharmaceutically acceptable carrier, excipient or diluent therefor.

References Cited (Backward Citations)

US3845058A Cited
US3886168A Cited
US3919230A Cited
US4035498A Cited
US4022791A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-04-09 1982-10-09 1983-04-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-04-09 1986-10-09 1987-04-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-04-09 1990-10-09 1991-04-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag